Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Longeveron
company
About
Longeveron is a life-sciences company that develops biological solutions for aging and aging-associated diseases.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $3.80M
- Industries
- Biotechnology,Life Science,Medical
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Longeveron is a life-sciences company that develops biological solutions for aging and aging-associated diseases. This is through the testing of allogeneic human Mesenchymal Stem Cells (MSCs) that are derived from the bone marrow of young, healthy donors. The Longeveron-grown Mesenchymal Stem Cell (LMSCs) product is manufactured in Longeveron’s cell processing facility located in Miami, Florida.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$4.55M
Longeveron has raised a total of
$4.55M
in funding over 2 rounds. Their latest funding was raised on
Oct 18, 2018 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 18, 2018 | Grant | $3.80M | 1 |
National Institutes of Health
|
— | Detail |
| May 22, 2018 | Grant | $750K | 1 |
TEDCO
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Longeveron is funded by 2 investors.
National Institutes of Health
and TEDCO
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
|
TEDCO
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
